US Stocks
/
Atrium Therapeutics, Inc. Share Price
Atrium Therapeutics, Inc. Share Price

Atrium Therapeutics, Inc. Share Price

NASDAQ: RNA | Small Cap
$8.42
+$0.12 (1.45%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Atrium Therapeutics, Inc. Stock Performance

Open
$8.26
Prev. Close
$8.30
Circuit Range
N/A
Day Range
$8.17 - $8.40
Year Range
$7.53 - $73.05
Volume
29,025
Average Traded
$8.25

Atrium Therapeutics, Inc. Share Price Today

As of 29 October 2026, Atrium Therapeutics, Inc.'s share price is $8.42. The stock opened at $8.26, compared to its previous close of $8.30. During today's trading session, Atrium Therapeutics, Inc.'s share price traded between $8.17 and $8.40, with an average price of $8.29. Over the past 52 weeks, the stock has recorded a high of $73.05 and a low of $7.53. In terms of performance, Atrium Therapeutics, Inc.'s share price has declined by 34.01% over the last six months and is down 87.94% on a year-on-year basis.

Atrium Therapeutics, Inc. Share Price Chart

$8.17$8.40
L
Show Current Price
H

Atrium Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$939.52M
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$18.76B
Return On Equity (TTM)
N/A
Profit Margin
-3649.41%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
88.43%

Atrium Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$12.48$0.86$19.64$3.00
Net Profit-$174.44-$237.10-$16.63-$20.19
Net Profit Margin-1397.76%-27569.77%-84.67%-673.00%
Income ChangeN/A-35.92%92.99%-21.41%

Atrium Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.22$9.56$10.90$18.76
Net Profit-$174.00-$212.22-$322.30-$684.63
Net Profit Margin-1887.20%-2219.87%-2956.88%-3649.41%
Income ChangeN/A-21.97%-51.87%-112.42%

About Atrium Therapeutics, Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Atrium Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$8.37
$8.40
+1.14%
Sep 2026
$13.30
$8.30
-40.34%
Aug 2026
$11.40
$13.92
+22.54%
Jul 2026
$13.42
$11.36
-15.35%
Jun 2026
$12.60
$13.42
+3.31%
May 2026
$13.15
$12.99
+1.80%
Apr 2026
$13.66
$12.76
-4.38%
Mar 2026
$14.13
$13.35
-9.68%
Feb 2026
$72.53
$14.78
-79.64%
Jan 2026
$72.10
$72.57
+0.61%
Dec 2025
$71.49
$72.13
+0.54%
Nov 2025
$69.81
$71.74
+2.73%

RNA Share Price FAQs

What is Atrium Therapeutics, Inc. share price today?

chevron-up
Atrium Therapeutics, Inc. share price today is $8.42 as on October 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Atrium Therapeutics, Inc. stock?

chevron-up
The 52 week high of Atrium Therapeutics, Inc. stock is $73.05, while the 52 week low is $7.53 as of 29 Oct '26.

What is RNA's market capitalisation today?

chevron-up
RNA market capitalisation is $939.52M as of October 29, 2026, at 4:55 am IST.

What is RNA's net income for the last quarter?

chevron-up
RNA's net income for the last quarter is -20.19B USD.

What is the 5 year returns of RNA?

chevron-up
The 5 year returns of RNA is -62.58% as on 29 Oct '26.

What is the high & low stock price of RNA today?

chevron-up
RNA stock price hit a high of $8.40 and low of $8.17 as of 29 Oct '26.

Can I buy RNA shares in India?

chevron-up
Yes. You can buy RNA in India by opening an international trading account.